Business
IceCure Announces Thomas Hospital of Infirmary Health Installs ProSense®, Becomes First Hospital in Alabama to Offer Breast Cancer Cryoablation
IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), a developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced Thomas Hospital of Fairhope, Alabama, part of the Infirmary Health network of hospitals, purchased and installed the ProSense® system, becoming the first facility in Alabama to offer breast cancer cryoablation. Dr. Katelin Holmes, a board-certified breast surgeon, Med
About this update from Icecure Medical Ltd.
[{"type":"text","content":"First procedures to be performed in the coming weeks at Alabama's largest non-governmental healthcare system","length":112,"tagName":"p","attribs":{}},{"type":"text","content":"Purchase funded by the Thomas Foundation following FDA marketing authorization of ProSense® in low-risk breast cancer and inclusion of cryoablation in proposed medical society guidelines","length":186,"tagName":"p","attribs":{}},{"type":"text","content":"CAESAREA, Israel, Feb. 19, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), a developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced Thomas Hospital of Fairhope, Alabama, part of the Infirmary Health network of hospitals, purchased and installed the ProSense® system, becoming the first facility in Alabama to offer breast cancer cryoablation. Dr. Katelin Holmes, a board-certified breast surgeon, Medical Director of Breast Surgical Services at Thomas Hospital, and Co-Director of the National Accreditation Program for Breast Centers ("NAPBC") Breast Program, will be selecting patients for the procedures, some of which are scheduled to commence their treatment this month.","length":863,"tagName":"p"},{"type":"image","alt":"IceCure_Medical_Logo","displaySize":"","headline":null,"caption":"IceCure_Medical_Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":200,"url":"https://media.zenfs.com/en/prnewswire.com/b733b9648e0c5c7b36e9d5bf48d042cc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/2XUcwzAVdZCf5Oz2LQaIEw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM1MztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/b733b9648e0c5c7b36e9d5bf48d042cc","width":400,"height":200}}},{"type":"text","content":""Thomas Hospital and Infirmary Health are leading the advancement of breast care in Alabama, where they serve a large population of women from around the Gulf Coast region. We are very pleased that with ProSense®, they will provide the very first breast cancer cryoablation procedures in Alabama over the coming weeks," stated IceCure's Vice President of Sales, North America, Shad Good. "We believe the installation comes on the heels of increased interest in ProSense® following th...